Across TCGA pan-cancer cohorts, MED15P9 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MED15P9’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MED15P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MED15P9 is over-expressed in tumor.

BRCA, LUSC, and UCEC are the cancer types where MED15P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MED15P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.098	.015	4	view →
LUSC	All	All	+0.323	.009	2	view →
UCEC	All	All	+0.243	.044	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MED15P9 RNA expression & survival · all MED15P9 data types